Interleukin 1, a mediator of immunoadjuvant peptidoglycans.
Bacterial peptidoglycans and the synthetic analog muramyl dipeptide possess various immunomodulating properties (adjuvant effect, increase of resistance to infectious agents and to tumor growth). They are able to induce B cell activation and to stimulate macrophages to produce monokines such as Interleukin 1 (IL 1). IL 1 plays an essential role in immune response. It promotes thymocytes maturation and Interleukin 2 secretion by antigen sensitive T cells, which in turn triggers regulatory T cells. Moreover, it is involved in the proliferation and differentiation of B cells. There is a correlation between the immunoenhancing effect of PG of a definite structure and their ability to induce IL 1 secretion. Non-adjuvant PG were inactive. This suggests that one of the major mechanisms of action of adjuvant PG could be the stimulation of IL 1 synthesis.
Guenounou
M
M
Vacheron
F
F
Nauciel
C
C
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000276:immunology / Q000494:pharmacology*; D000276:Adjuvants, Immunologic; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology / Q000378:metabolism; D002454:Cell Differentiation; D002455:Cell Division; D007111:Immunity, Cellular; D007375:Interleukin-1 / Q000096:biosynthesis* / Q000276:immunology / Q000494:pharmacology; D007376:Interleukin-2 / Q000378:metabolism; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology / Q000378:metabolism*; D010457:Peptidoglycan / Q000276:immunology / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
D000276:Adjuvants, Immunologic; D007375:Interleukin-1; D007376:Interleukin-2; D010457:Peptidoglycan; D000119:Acetylmuramyl-Alanyl-Isoglutamine